Suchergebnisse - "Kim, Haesook T"

PubPharm (12)

1

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation : randomized phase II results

enthalten in: Haematologica | 2018

von Koreth, J. | Kim, H. | Lange, P. | +17

CommentIn: Haematologica. 2018 Mar;103(3):377-379. - PMID 29491127

2

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Soiffer, R. | Kim, H. | McGuirk, J. | +29

CommentIn: J Clin Oncol. 2017 Dec 20;35(36):3993-3995. - PMID 29087771

3

The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma : a multicentre randomized trial

enthalten in: British journal of haematology | 2016

von Armand, P. | Kim, H. | Sainvil, M. | +15

4

A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation : A Phase II Trial

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2015

von Koreth, J. | Kim, H. | Lange, P. | +13

5

Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Koreth, J. | Stevenson, K. | Kim, H. | +10

CommentIn: J Clin Oncol. 2012 Sep 10;30(26):3160-1. - PMID 22869873

6

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors

enthalten in: Blood | 2009

von Koreth, J. | Stevenson, K. | Kim, H. | +8

7

Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2009

von Ho, V. | Aldridge, J. | Kim, H. | +6

8

Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2008

von Armand, P. | Gannamaneni, S. | Kim, H. | +12

CommentIn: J Clin Oncol. 2009 Oct 1;27(28):e138; author reply e139-40. - PMID 19720890

9

Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2008

von Alyea, E. | Li, S. | Kim, H. | +4

10

Mucositis after allogeneic hematopoietic stem cell transplantation : a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2005

von Cutler, C. | Li, S. | Kim, H. | +10